Patents
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
10/2007
10/23/2007US7285572 Compounds as for example, 2'-[1-[(2R)-3-[[1-(3-fluoro-4-methylphenyl)-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]ethyl]-3-methylbiphenyl-4-carboxylic acid, having a calcium-sensing receptor antagonistic action; therapeutic drug for osteoporosis
10/23/2007US7285565 E.g., 3-(2-(4-[(2-aminosulfonyl)phenyl]benzoylamino)phenoxy)benzamidine; 7-(2-(4-[(2-aminosulfonyl)phenyl]benzoylamino)-4-trifluoromethylphenoxy)1-aminoisoquinoline; and 3-hydroxycarbonyl-2-(4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenoxynaphthalene; highly selective
10/23/2007US7285547 E.g., N'-hydroxy-3-((1-((2-methyl-1-piperidinyl)carbonyl)-2-(2 -naphthylsulfonyl)hydrazino)methyl)benzenecarboximidamide
10/18/2007WO2007117981A2 Selective hydroxamate based mmp inhibitors
10/18/2007WO2007116374A1 Novel sulfonamide compounds
10/18/2007WO2007116314A1 N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
10/18/2007WO2007054257A3 Indene derivatives, their preparation and use as medicaments
10/18/2007US20070244197 Bactericide against gramnegative bacteria; respiratory system disorders
10/18/2007US20070244156 Sulfonylamino-acetic acid derivatives
10/18/2007CA2648978A1 N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
10/18/2007CA2646917A1 Novel sulfonamide compounds
10/18/2007CA2644783A1 Selective hydroxamate based mmp inhibitors
10/17/2007EP1845083A2 New arylsulfonohydrazide inhibitors of enzymes MurC and MurD
10/17/2007EP1844002A1 1-acylamino-2-hydroxy-3-amino-w-arylalkanes as renin inhibitors
10/17/2007EP1708991B1 Sulfonamide derivatives for the treatment of diseases
10/17/2007EP1565438B1 Antitumor benzoylsulfonamides
10/17/2007CN101053561A Methods and compositions useful for inhibition of alpha v beta 5 mediated angiogenesis
10/17/2007CN101053558A Diphenylethylene compounds and uses thereof
10/17/2007CN100343227C Process for resolution of tamsulosin
10/16/2007US7282595 Therapy of adenocarcinoma of the colon and rectum
10/16/2007US7282592 Resorcinol derivatives
10/16/2007US7282502 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis; N-(2-Benzoyl-4-chloro-phenyl)-4-chloro-benzenesulfonamide; N-[4-Chloro-2-(pyridin-2-ylsulfanyl)-phenyl]-4-isopropyl-benzenesulfonamide
10/16/2007US7282496 Rheumatic diseases; bone disorders; Aids; antiinflammatory agents
10/16/2007US7282363 Container body for the culture of embryos, sized and configured for intravaginal accommodation, a resealable closure permitting selective access to the interior of the container body; collecting and retrieval of embryos
10/16/2007CA2291438C Nitration process for diphenyl ethers
10/11/2007WO2007114532A1 Novel chalcone derivatives, pharmaceutically acceptable salt, method for preparation and uses thereof
10/11/2007WO2007087949A3 Oxonium and sulfonium salts
10/11/2007US20070238781 Compounds for the modulation of the glykolysis-enzyme-and/or of the transaminase-complex
10/11/2007US20070238763 Urea derivatives as integrin a4 antagonists
10/10/2007EP1841731A1 Substituted aminomethylene sulphonamides, production and use thereof as medicaments
10/10/2007CN101050193A Nitric ester derivatives, its medicinal composition and their medicinal use
10/10/2007CN101049296A Nitric ester derivatives and use in treatment of urinary incontinence and other diseases
10/10/2007CN100341850C Salts of demethyl phencynonate isomer and N-para-methyl-phenyl-sulfuryl glutamic acid optical isomer and their preparing method and use
10/10/2007CN100341496C Preventive or therapeutic agent for kidney disease
10/09/2007US7279578 Use as orexin receptor antagonists, depression; anxiety; addictions; obsessive compulsive disorder; affective neurosis; depressive neurosis; anxiety neurosis; dysthymic disorder; behaviour disorder; mood disorder; sexual dysfunction; psychosexual dysfunction; schizophrenia; manic depression; delerium
10/09/2007US7279478 Cathepsin cysteine protease inhibitors
10/09/2007US7279477 Cardiovascular disease, diabetes, acidosis, cancer, obesity; such as 1-butyl-3,3-dimethyl-1-(4-(2,2,2-trifluoro-1-hydroxy-1-trifluoromethyl -ethyl)-phenyl)-thiourea
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/09/2007CA2204527C 2,2-dichloralkane-carboxylic acids, processes for their production and pharmaceutical agents containing these
10/04/2007WO2007110876A2 Novel sulfonanilide derivatives, pharmaceutical compositions comprising the same and process thereof
10/04/2007WO2007060215A3 (r)-arylkylamino derivatives and pharmaceutical compositions containing them
10/04/2007US20070231647 Proton Conductor and Fuel Cell Using the Same
10/04/2007DE102006013957A1 Substituierte N-Benzyl-N-phenylbenzolsulfonamide Substituted N-benzyl-N-phenylbenzolsulfonamide
10/03/2007EP1838773A1 Fluorochemical diesters as repellent polymer melt additives
10/03/2007EP1519932B1 Bisarylsulfonamide compounds and their use in cancer therapy
10/03/2007EP1511722B1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof
10/03/2007EP1294378B1 Thrombopoietin mimetics
10/03/2007EP1183232B1 Monofluoroalkyl derivatives
10/02/2007US7276607 5-HT7 receptor antagonists
10/02/2007CA2096407C Retroviral protease inhibitors
09/2007
09/27/2007WO2007109175A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
09/27/2007WO2007107828A2 Amine derivatives
09/27/2007US20070225528 Process for Producing Optically Active Alcohol
09/27/2007US20070225365 Cetp Inhibitors
09/27/2007US20070225327 3-Methyl-2-[4'-(pyridin-3-ylmethoxymethyl)-biphenyl-4-sulfonylamino]-butyric acid; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis
09/27/2007US20070224263 Aminoalkylphosphonates and related compounds as Edg receptor agonists
09/26/2007EP1836182A2 Heterocyclylbiphenyl derivates as protein tyrosine phosphatase inhibitors
09/26/2007EP1383750B1 Urea derivatives as integrin alpha 4 antagonists
09/26/2007EP1341753B1 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
09/26/2007EP1302461B1 Tnf-alpha production inhibitors
09/25/2007US7273863 Benzophenones as inhibitors of reverse transcriptase
09/25/2007CA2415551C Aniline derivatives
09/20/2007WO2007104144A1 Compounds, ionic liquids, molten salts and uses thereof
09/20/2007US20070219382 chemical synthesis; catalytic preparation for (2R)-2-{[(4-Fluoro-3-methylphenyl)sulfonyl]amino}-N-hydroxy-2(tetrahydro-2H-pyran-4-yl)acetamide; make potent lethal factor (LF) inhibitors for the treatment of anthrax; bactericides
09/20/2007US20070219217 Triazolone Derivatives as Mmp Inhibitors for the Treatment of Asthma and Copd
09/20/2007US20070219215 Thioamides and Salts Thereof and Cytokine Production Inhibitors Containing Both
09/19/2007CN101039928A Method for cleaning 3-hydroxyamidinophenylalanine derivatives by the precipitation and recrystallisation of a salt and an aromatic sulphonic acid
09/19/2007CN101039900A 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
09/19/2007CN101037403A Method for synthesizing anti-aids drug amprenavir intermediate
09/19/2007CN101037402A Preparation method of R-5-(2-Aminopropyl)-2-methoxybenzenesulfonyl with high optically active purity
09/19/2007CN100338031C Compounds and methods for synthesis and therapy
09/18/2007USRE39850 Aryl amide, -sulfonamide, or -urea derivatives; antiproliferative, antitumor, anticarcinogenic, and/or antimetastasis agents
09/18/2007US7271228 Ionic perfluorovinyl compounds and their uses as components of ionic conductors of the polymer type, of selective membranes or of catalysts
09/18/2007US7271197 prophylaxis and treatment of respiratory diseases; compounds having potent and selective stimulant action at beta 2-adrenoreceptors and having an advantageous profile of action
09/18/2007US7271188 e.g. 4-[3'-(3''-aminosulfonylpropyl)-4',4'-dimethyl-5'-oxo-2'-thioxo-1'-imidazolidinyl]-2-trifluoromethylbenzonitrile; anti-androgen agent which has a sufficient antagonistic effect and reduced side effect profile
09/18/2007CA2211982C Substituted indanylidineacetylguanidines, process for their preparation,their use as medicaments or diagnostic and medicaments containing them
09/13/2007WO2007027524A3 Halo active aromatic sulfonamide organic compounds and odor control uses therefor
09/13/2007WO2007027420A3 Compositions of fluorochemical surfactants
09/13/2007US20070213348 Chemical Compounds
09/13/2007US20070213333 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate
09/13/2007US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/12/2007EP1831158A1 Novel cyclohexane derivatives
09/12/2007EP1831157A2 Nonnucleoside inhibitors of hiv-1 reverse transcriptase
09/12/2007EP1379239B1 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor
09/12/2007CN101033206A Method of preparing 2-chloro-3-nitro-5-carboxyl benzenesulfonamide
09/12/2007CN100336806C Sulfonyl urea compounds and herbicidal activity thereof
09/12/2007CN100336805C Chiral sulfonamide-aminol ligand and preparation method and uses
09/11/2007US7268147 For therapy of inflammatory, allergic and respiratory diseases
09/11/2007US7268135 Biaryl sulfonamides and methods for using same
09/11/2007CA2318368C Novel tricyclic compound
09/11/2007CA2255858C Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
09/06/2007US20070205388 Acidity and dissociation; stability, for doping polymers, as electrolytes in batteries
09/05/2007EP1828110A1 Process for the preparation of tamsulosin and intermediates thereof
09/05/2007EP1373233B1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
09/05/2007EP1153016B1 Phenylsulfonyl ureas, methods for producing them and their use as herbicides and plant growth regulators
09/05/2007CN101031539A Substituted arylalkanoic acid derivatives and use thereof
09/05/2007CN100335461C Arylsulfonanilide ureas
09/04/2007US7265220 Amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
09/04/2007US7265130 anti-obestic activity; Neuropeptide Y antagonist
08/2007
08/30/2007WO2007098030A1 Selective n-sulfonylation of 2-amino trifluoroalkyl substituted alcohols
1 ... 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 ... 177